ANDA 75065, held by Hospira. Acyclovir Sodium.
As of Nov 14, 2026, ANDA 75065 (Acyclovir Sodium), held by Hospira, was first approved by FDA on Feb 25, 1999, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 25, 1999 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Acyclovir SodiumEQ 50MG BASE/ML ยท injectable;injection | Acyclovir Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
